Editor's Choice
2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 infection, and return to play.
17 Mar, 2022 | 09:26h | UTCCommentaries:
ACC Issues Clinical Guidance on CV Consequences of COVID-19 – American College of Cardiology
ACC Releases Guidance on CV Issues With COVID-19 – TCTMD
Key Points: 2022 ACC Decision Pathway on Cardiovascular Sequelae of COVID-19
Related:
Review | Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus.
The pathogenesis and long-term consequences of Covid-19 cardiac injury: state-of-the-art review.
COVID-19 infections increase risk of heart conditions up to a year later, study finds.
Commentary on Twitter (thread – click for more)
Access the full ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-acute Sequelae of SARS-CoV-2 Infection, and Return to Play: https://t.co/ph75qZxfpT #JACC @JACCJournals #CardioTwitter (8/8) pic.twitter.com/mpYJic6gem
— American College of Cardiology (@ACCinTouch) March 16, 2022
Among health care workers, a fourth dose vaccine effectiveness against any SARS-CoV-2 Omicron variant infection was 30% for the Pfizer–BioNTech and 11% for the Moderna.
17 Mar, 2022 | 09:12h | UTCEfficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron – New England Journal of Medicine
Related: [Preprint] Fourth dose of COVID vaccine offers only slight boost against Omicron infection.
Treatments for moderate to severe COVID-19: Cochrane evidence.
17 Mar, 2022 | 09:19h | UTCTreatments for moderate to severe COVID-19: Cochrane evidence – Evidently Cochrane
Effectiveness of the Sputnik V, AstraZeneca, and Sinopharm vaccines for the risk of infection and death due to COVID-19 in people older than 60 years in Argentina.
17 Mar, 2022 | 09:10h | UTCCommentary: Evaluating COVID-19 vaccines in the real world – The Lancet
Treatments for mild COVID-19: Cochrane evidence.
17 Mar, 2022 | 09:17h | UTCTreatments for mild COVID-19: Cochrane evidence – Cochrane Library
[News release – not published yet] Empagliflozin phase III EMPA-KIDNEY trial will stop early due to evidence of efficacy in people with chronic kidney disease.
17 Mar, 2022 | 09:07h | UTC
Commentary on Twitter
Details of the design & pt characteristics now published:
6609 people from 8 countries
(UK, Germany, Italy, USA, Canada, China, Malaysia, Japan)
Mean age 64 years
1/3 female
1/2 diabetes; 1/2 without
3/4 eGFR <45 mL/min/1.73 m2.
1/2 uACR <300 mg/g https://t.co/jOD8kyp3i4 pic.twitter.com/YYpGPJDnV9— Martin Landray (@MartinLandray) March 16, 2022
Malignant Hypertension: Current perspectives and challenges.
17 Mar, 2022 | 09:03h | UTC
Denmark proposes ban on selling cigarettes to people born after 2010.
17 Mar, 2022 | 09:04h | UTCDenmark proposes ban on selling cigarettes to people born after 2010 – euronews
Commentary on Twitter
Happy to see this bold move by #Denmark to ban the sale of cigarettes to people born after 2010, and that the majority of 🇩🇰 people support this #NoTobacco decision. @WHO looks forward to working together to create ‘tobacco-free generations’ from now on.https://t.co/6BF0OeakrI
— Tedros Adhanom Ghebreyesus (@DrTedros) March 16, 2022
Open-Label, multicenter study of Flecainide Acetate oral inhalation solution for acute conversion of recent-onset, symptomatic atrial fibrillation to sinus rhythm.
17 Mar, 2022 | 09:01h | UTC
Commentary on Twitter
Inhalation of flecainide simply converts many episodes of recent onset atrial fibrillation #AHAJournals #HeartMonthhttps://t.co/vNXx4fKy2u pic.twitter.com/UNGA9DX3qM
— CircEP (@CirculationEP) February 25, 2022
USPSTF Recommendation Statement: There is insufficient evidence to recommend screening for eating disorders in adolescents and adults.
16 Mar, 2022 | 10:10h | UTCEditorials:
Prevention and Early Identification of Eating Disorders – JAMA
Author Interview: USPSTF Recommendation: Screening for Eating Disorders in Adolescents and Adults
AAP Policy Statement: Vitamin K and the newborn infant.
16 Mar, 2022 | 10:08h | UTCVitamin K and the Newborn Infant – Pediatrics
News Release: Vitamin K policy addresses birth dose for term, preterm infants; parental concerns – American Academy of Pediatrics
Commentary: Newborns Should Receive Vitamin K Within Six Hours of Birth – HealthDay
Italian guidelines for the treatment of type 2 diabetes.
16 Mar, 2022 | 10:06h | UTCItalian guidelines for the treatment of type 2 diabetes – Acta Diabetologica
Related:
Guideline: ADA 2022 Standards of Medical Care in Diabetes.
NICE Updated Guidance: Management of Type 2 Diabetes.
Recent updates to clinical practice guidelines for diabetes mellitus.
Systematic Review: Perioperative enhanced recovery programs for women with gynecological cancers.
16 Mar, 2022 | 10:05h | UTCPerioperative enhanced recovery programmes for women with gynaecological cancers – Cochrane Library
See also: Complete List of Enhanced Recovery After Surgery (ERAS) Society Guidelines (some guidelines are free)
Review: Role of imaging in rare COVID-19 vaccine multiorgan complications.
16 Mar, 2022 | 10:00h | UTCRole of imaging in rare COVID-19 vaccine multiorgan complications – Insights into Imaging
Review | Clinical application of intermittent fasting for weight loss: progress and future directions.
16 Mar, 2022 | 09:54h | UTCClinical application of intermittent fasting for weight loss: progress and future directions – Nature Reviews Endocrinology (if the link is paywalled, try this one)
Related:
M-A: Intermittent fasting and obesity-related health outcomes.
Intermittent fasting may be effective weight loss strategy in patients with type 2 diabetes
Systematic review: Intermittent fasting for the prevention of cardiovascular disease
Randomized trial: Effects of time-restricted eating in women and men with overweight and obesity
How good a diet is intermittent fasting?
Systematic Review: Intermittent Fasting and Weight Loss
Clinical Management of Intermittent Fasting in Patients with Diabetes Mellitus
Fasting Diets are Going Mainstream — Ahead of the Science. Here’s Why.
Commentary on Twitter
https://twitter.com/hugocorralesMD/status/1497569406024667138
Cohort Study | Breast arterial calcification: a novel cardiovascular risk enhancer among postmenopausal women.
16 Mar, 2022 | 09:56h | UTCBreast Arterial Calcification: a Novel Cardiovascular Risk Enhancer Among Postmenopausal Women – Circulation: Cardiovascular Imaging (link to abstract – $ for full-text)
News Release: Mammograms may provide clues about women’s risk for cardiovascular disease – AHA Newsroom
Commentaries:
More Evidence Links Breast Arterial Calcification and CVD Risk – TCTMD
Breast Arterial Calcification on Mammography Tied to CVD Risk – HealthDay
Related: Review: Role of Breast Arterial Calcification for Cardiovascular Risk Stratification in Women
Review: Persistent COVID and a return to sport.
16 Mar, 2022 | 09:51h | UTCPersistent COVID and a Return to Sport – Current Sports Medicine Reports
Quantitative chest CT assessment of small airways disease in post-acute SARS-CoV-2 infection.
16 Mar, 2022 | 09:53h | UTCNews Release: ‘Long COVID’ linked to lasting airways disease – Radiological Society of North America
M-A: Association of low- and no-calorie sweetened beverages as a replacement for sugar-sweetened beverages with body weight and cardiometabolic risk.
16 Mar, 2022 | 09:49h | UTCCommentary: Alternative sweeteners in your drinks can help with weight and diabetes risk, study says – CNN
Commentary on Twitter
Meta-analysis of 17 trials found low-calorie sweetened beverages were associated with improvement in body weight and metabolic risk, suggesting they may be a viable alternative to water when replacing sugar-sweetened beverages in overweight & obese adults. https://t.co/coz3U4pIZA
— JAMA Network Open (@JAMANetworkOpen) March 14, 2022
[Preprint] High vaccine effectiveness against severe Covid-19 in the elderly in Finland before and after the emergence of Omicron.
15 Mar, 2022 | 09:59h | UTC
Commentary on Twitter
The acid test for Covid vaccines are protection of the elderly. New data from ~900,000 Finns age 70+ show how 3 shots achieved 96% effectiveness vs hospitalization, before and after Omicron, and even higher vs ICU need https://t.co/TQOQV4SL9a Spikevax=Moderna; Comirnaty=Pfizer pic.twitter.com/mtUCqne1dT
— Eric Topol (@EricTopol) March 14, 2022
COVID-19 and resilience of healthcare systems in ten countries.
15 Mar, 2022 | 10:02h | UTCCOVID-19 and resilience of healthcare systems in ten countries – Nature
M-A: Evaluating the association between LDL Cholesterol reduction and relative and absolute effects of statin treatment.
15 Mar, 2022 | 10:04h | UTCEvaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis – JAMA Internal Medicine (free for a limited period)
Commentary from the author: Benefits of statins may have been overstated – new study – The Conversation
Commentary on Twitter
Our study in @JAMAInternalMed asked 2 questions 1. Is reducing one’s ‘bad’ cholesterol was associated with a proportional reduction in death, heart attack and stroke? 2. What's the absolute reduction in risk from taking statins? https://t.co/Zwh7LmUD0e
— Dr Paula Byrne (@pbyrne82) March 14, 2022
Review | Resistance exercise as a treatment for sarcopenia: prescription and delivery.
15 Mar, 2022 | 09:55h | UTCResistance exercise as a treatment for sarcopenia: prescription and delivery – Age and Ageing
Extracorporeal membrane oxygenation (ECMO) in COVID-19 patients: a pocket guide for radiologists.
15 Mar, 2022 | 09:51h | UTC
Caring for older adults during the COVID-19 pandemic.
15 Mar, 2022 | 09:48h | UTCCaring for older adults during the COVID-19 pandemic – Clinical Microbiology and Infection